n.a. (ARIA)

0.00
NASDAQ
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NASDAQ
Div & Yield N.A. (N.A)
Today's Pre-Market Trading Very Positive For Ariad Pharmaceuticals (ARIA)

Today's Pre-Market Trading Very Positive For Ariad Pharmaceuticals (ARIA)

Trade-Ideas LLC identified Ariad Pharmaceuticals (ARIA) as a pre-market leader candidate

Biotech Stocks Partying Like It's 1999

Biotech Stocks Partying Like It's 1999

After a weak October, biotech stocks have rebounded in a big way in November. The sector is on pace for an history year of absolute and relative performance.

Four Biotech 'Surprise' Stocks for 2014

Four Biotech 'Surprise' Stocks for 2014

Biotech investing rarely follows a predictable script, so here's four stocks which may surprise even the most experienced investors in 2014.

Ariad Pharmaceuticals (ARIA) In A Perilous Reversal

Ariad Pharmaceuticals (ARIA) In A Perilous Reversal

Trade-Ideas LLC identified Ariad Pharmaceuticals (ARIA) as a "perilous reversal" (up big yesterday but down big today) candidate

'Mad Money' Lightning Round: Buy, Buy, Buy Splunk

'Mad Money' Lightning Round: Buy, Buy, Buy Splunk

Cramer is over the moon on Orbital Sciences but thinks iRobot is too dangerous.

Jim Cramer's 'Mad Money' Recap: A Glass-Half-Full Market

Jim Cramer's 'Mad Money' Recap: A Glass-Half-Full Market

There are silver linings in this quarter's earnings that the naysayers seem to be largely ignoring, Cramer says.

Why Ariad Pharmaceuticals (ARIA) is Soaring

Why Ariad Pharmaceuticals (ARIA) is Soaring

Ariad Pharmaceuticals (ARIA) is up, up, and away, after good news on Friday had the stock extending its rally through to Monday.

Trade-Ideas: Ariad Pharmaceuticals (ARIA) Is Today's "Barbarian At The Gate" Stock

Trade-Ideas: Ariad Pharmaceuticals (ARIA) Is Today's "Barbarian At The Gate" Stock

Trade-Ideas LLC identified Ariad Pharmaceuticals (ARIA) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

Biotech Stocks Underperforming? These Charts Says Otherwise

Biotech Stocks Underperforming? These Charts Says Otherwise

Biogen Idec and Gilead Sciences are helping the biotech sector recover from a sloppy fourth quarter performance.

Ariad Pharmaceuticals (ARIA) Trading With Heavy Volume Before Market Open

Ariad Pharmaceuticals (ARIA) Trading With Heavy Volume Before Market Open

Trade-Ideas LLC identified Ariad Pharmaceuticals (ARIA) as a pre-market mover with heavy volume candidate

Europe Allows Ariad to Keep Selling Leukemia Drug, Shares Rise

Europe Allows Ariad to Keep Selling Leukemia Drug, Shares Rise

European regulators place new patient restrictions on Iclusig but Ariad can continue to sell the drug.

ARIAD Announces Positive Opinion By The European Medicines Agency On The Continued Availability Of Iclusig In Patients With Leukaemias

ARIAD Announces Positive Opinion By The European Medicines Agency On The Continued Availability Of Iclusig In Patients With Leukaemias

ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) today announced adoption of a positive opinion by the Committee for Human Medicinal Products (CHMP) of the European Medicines Agency (EMA) on the continued availability of ...

3 Biotech Stocks Under $10 Moving Higher

3 Biotech Stocks Under $10 Moving Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Shareholder Rights Law Firm Johnson & Weaver, LLP Files Derivative Lawsuit On Behalf Of ARIAD Pharmaceuticals, Inc.

Shareholder Rights Law Firm Johnson & Weaver, LLP Files Derivative Lawsuit On Behalf Of ARIAD Pharmaceuticals, Inc.

Johnson & Weaver, LLP filed a derivative lawsuit seeking to hold certain officers and directors of ARIAD Pharmaceuticals, Inc.

ARIAD Reports Third Quarter 2013 Financial Results And Announces Significant Expense Reduction

ARIAD Reports Third Quarter 2013 Financial Results And Announces Significant Expense Reduction

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today reported financial results for the third quarter of 2013, including revenue from Iclusig ® (ponatinib).

ARIAD Announces Reduction In U.S. Workforce As Part Of Broad Program To Reduce Operating Expenses

ARIAD Announces Reduction In U.S. Workforce As Part Of Broad Program To Reduce Operating Expenses

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it is reducing approximately 40 percent of its staff positions in the United States following its decision to temporarily suspend the marketing and ...

Ariad Pharmaceuticals (ARIA) Marked As A Dead Cat Bounce Stock

Ariad Pharmaceuticals (ARIA) Marked As A Dead Cat Bounce Stock

Trade-Ideas LLC identified Ariad Pharmaceuticals (ARIA) as a "dead cat bounce" (down big yesterday but up big today) candidate

The Drive Behind Ariad Pharmaceuticals' (ARIA) Partial Recovery

The Drive Behind Ariad Pharmaceuticals' (ARIA) Partial Recovery

Ariad Pharmaceuticals (ARIA) is making a slow recovery from its 86% loss in value over the past month.

ARIAD Adopts Shareholder Rights Plan To Preserve Valuable Net Operating Loss Carryforwards And Other Tax Benefits

ARIAD Adopts Shareholder Rights Plan To Preserve Valuable Net Operating Loss Carryforwards And Other Tax Benefits

ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) announced today that its Board of Directors has adopted a shareholder rights plan in the form of a Section 382 Rights Agreement designed to preserve its substantial tax ...

Biotech Stock Mailbag: Chelsea's FDA Panel, Ariad's Future, Bio-Bubble Update

Biotech Stock Mailbag: Chelsea's FDA Panel, Ariad's Future, Bio-Bubble Update

Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

Why These 3 Companies Tanked: WTW, ARIA, AVP

Why These 3 Companies Tanked: WTW, ARIA, AVP

Weight Watchers (WTW), Ariad Pharmaceuticals (ARIA) and Avon Products (AVP) suffered double-digit losses in Thursday trading.

ARIAD Announces Change To The Date Of Its Third Quarter 2013 Financial Results Conference Call And Webcast To November 12, 2013

ARIAD Announces Change To The Date Of Its Third Quarter 2013 Financial Results Conference Call And Webcast To November 12, 2013

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will change the date of its third quarter 2013 conference call to Tuesday, November 12, 2013, at 8:30 a.

The Reasons Behind Ariad Pharma's Double-Digit Selloff

The Reasons Behind Ariad Pharma's Double-Digit Selloff

Ariad Pharmaceuticals sunk 39% following the marketing suspension of its only cancer drug.

Heavy Volume And Pre-Market Movement For Ariad Pharmaceuticals (ARIA)

Heavy Volume And Pre-Market Movement For Ariad Pharmaceuticals (ARIA)

Trade-Ideas LLC identified Ariad Pharmaceuticals (ARIA) as a pre-market mover with heavy volume candidate

ARIAD Announces Temporary Suspension Of Iclusig Marketing In The United States

ARIAD Announces Temporary Suspension Of Iclusig Marketing In The United States

ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) today announced that it is temporarily suspending the marketing and commercial distribution of Iclusig ® (ponatinib), a treatment for patients with resistant or...

Today's Dead Cat Bounce Stock: Ariad Pharmaceuticals (ARIA)

Today's Dead Cat Bounce Stock: Ariad Pharmaceuticals (ARIA)

Trade-Ideas LLC identified Ariad Pharmaceuticals (ARIA) as a "dead cat bounce" (down big yesterday but up big today) candidate

Ariad Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors

Ariad Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, and the securities litigation firm of Powers Taylor LLP announce that a federal class action...

Ariad Pharmaceuticals (ARIA) Is Today's Perilous Reversal Stock

Ariad Pharmaceuticals (ARIA) Is Today's Perilous Reversal Stock

Trade-Ideas LLC identified Ariad Pharmaceuticals (ARIA) as a "perilous reversal" (up big yesterday but down big today) candidate

Biotech Stock Mailbag: Vanda, Onconova, Catalyst Pharma, Sarepta

Biotech Stock Mailbag: Vanda, Onconova, Catalyst Pharma, Sarepta

Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These under-$10 stocks look ready to trade higher from current levels.